相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
Heinz-Josef Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series
Maurice B. Loughrey et al.
HISTOPATHOLOGY (2021)
Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors
Kiwamu Akagi et al.
CANCER SCIENCE (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer
Naohiro Tomita et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC).
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Immunotherapy rechallenge after nivolumab treatment in advanced non small cell lung cancer in the real-world setting: A national data base analysis
Matteo Giaj Levra et al.
LUNG CANCER (2020)
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th edition
Hiromichi Ebi et al.
CANCER SCIENCE (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability high (MSI-H) tumors.
Neil Howard Segal et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
Benjamin Goeppert et al.
BRITISH JOURNAL OF CANCER (2019)
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Alicia Latham et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
Romain Cohen et al.
JAMA ONCOLOGY (2019)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M. Lupinacci et al.
GASTROENTEROLOGY (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
Christina Therkildsen et al.
MOLECULAR ONCOLOGY (2018)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients
Ari Vanderwalde et al.
CANCER MEDICINE (2018)
Utility of the quasi-monomorphic variation range in unresectable metastatic colorectal cancer patients
Hideaki Bando et al.
CANCER SCIENCE (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency
Musa AlHarbi et al.
ONCOLOGIST (2018)
Sustained complete response of recurrent glioblastoma to combined checkpoint inhibition in a young patient with constitutional mismatch repair deficiency
Valerie Larouche et al.
PEDIATRIC BLOOD & CANCER (2018)
DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer
Jisup Kim et al.
CANCERS (2018)
Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome
Dora Huang et al.
BLADDER CANCER (2018)
Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome
Jordan M. Cloyd et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome
Holly L. Harper et al.
MODERN PATHOLOGY (2017)
Hypermutation In Pancreatic Cancer
Jeremy L. Humphris et al.
GASTROENTEROLOGY (2017)
Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers A Potential Cause for False-Negative Results?
Yang Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
Akira Hirasawa et al.
ONCOTARGET (2017)
Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma
Jordan M. Cloyd et al.
JAMA SURGERY (2017)
Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data
Sumit Middha et al.
JCO PRECISION ONCOLOGY (2017)
Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1
K. Wimmer et al.
CLINICAL GENETICS (2017)
Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor
Kenji Fujiyoshi et al.
ANTICANCER RESEARCH (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
The Nationwide Cancer Genome Screening Project for Gastrointestinal Cancer in Japan (GI-SCREEN): MSI-status and cancer-related genome alterations in advanced colorectal cancer (CRC)-GI-SCREEN 2013-01-CRC sub-study.
Takeshi Kajiwara et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
MSIplus for Integrated Colorectal Cancer Molecular Testing by Next-Generation Sequencing
Jennifer A. Hempelmann et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma
Maziar Riazy et al.
MODERN PATHOLOGY (2015)
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortium
Doua Bakry et al.
EUROPEAN JOURNAL OF CANCER (2014)
Is Microsatellite Instability a Prognostic Marker in Gastric Cancer?: A Systematic Review With Meta-Analysis
Yoon Young Choi et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Cancer Risks for MLH1 and MSH2 Mutation Carriers
James G. Dowty et al.
HUMAN MUTATION (2013)
A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA
Deepa T. Patil et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
Ji Yeong An et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair-Defective Colorectal Carcinomas A Report of the Association for Molecular Pathology
William K. Funkhouser et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Yield of routine molecular analyses in colorectal cancer patients=70 years to detect underlying Lynch syndrome
Margot G. F. van Lier et al.
JOURNAL OF PATHOLOGY (2012)
Recurrence and Variability of Germline EPCAM Deletions in Lynch Syndrome
Roland P. Kuiper et al.
HUMAN MUTATION (2011)
De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one
Ajay Goel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines
Emanuela Romano et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Laura Baglietto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Colorectal Cancer Due to Deficiency in DNA Mismatch Repair Function A Review
Andrew M. Bellizzi et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome A 2-antibody Panel May be as Predictive as a 4-antibody Panel
Jinru Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B
Shin-ichi Asaka et al.
CARCINOGENESIS (2009)
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E. Barrow et al.
CLINICAL GENETICS (2009)
Germline Hypermethylation of MLH1 and EPCAM Deletions Are a Frequent Cause of Lynch Syndrome
Renee C. Niessen et al.
GENES CHROMOSOMES & CANCER (2009)
Management of extracolonic tumours in patients with Lynch syndrome
Jan J. Koornstra et al.
LANCET ONCOLOGY (2009)
Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening
Catherine Julie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology
Tuya Pal et al.
CLINICAL CANCER RESEARCH (2008)
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Kohzoh Imai et al.
CARCINOGENESIS (2008)
Pathologic features of endometrial carcinoma associated with HNPCC - A comparison with sporadic endometrial carcinoma
RR Broaddus et al.
CANCER (2006)
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining
E Mangold et al.
JOURNAL OF PATHOLOGY (2005)
HNPCC-associated small bowel cancer:: Clinical and molecular characteristics
K Schulmann et al.
GASTROENTEROLOGY (2005)
Mononucleotide repeats BAT-26 and BAT-25 accurately detect MSI-H tumors and predict tumor content: Implications for population screening
C Brennetot et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder
JC Roa et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers
F Chiappini et al.
CARCINOGENESIS (2004)
Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas
K Koinuma et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
E Domingo et al.
JOURNAL OF MEDICAL GENETICS (2004)
The clinical features of rectal cancers with high-frequency microsatellite instability (MSI-H) in Japanese males
T Ishikubo et al.
CANCER LETTERS (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
PJ Goodfellow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Genomic medicine - Hereditary colorectal cancer
HT Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
